Quick Takeaways
- Samsara BioCapital, L.P. filed SCHEDULE 13D/A for VTV THERAPEUTICS INC. Class A Common Stock, par value $0.01 per share (VTVT).
- Disclosed ownership: 9.9%.
- Date of event: 29 Aug 2025.
Samsara BioCapital, L.P. - 29 Aug 2025 SCHEDULE 13D/A Report for VTV THERAPEUTICS INC. Class A Common Stock, par value $0.01 per share (VTVT)
- Filing Manager
- Samsara BioCapital, L.P.
- Reporting Manager
- Srinivas Akkaraju
- Symbol
- VTVT
- Shares outstanding
- 3,466,899 shares
- Disclosed Ownership
- 343,223 shares
- Ownership
- 9.9%
- Form type
- SCHEDULE 13D/A
- Filing time
- 03 Sep 2025, 19:33:39 UTC
- Date of event
- 29 Aug 2025
- Next filing
- 25 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Samsara BioCapital, L.P. disclosed 9.9% ownership in VTV THERAPEUTICS INC. Class A Common Stock, par value $0.01 per share (VTVT) on 29 Aug 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 03 Sep 2025, 19:33.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Samsara BioCapital, L.P. | 9.9% | 339,157 | 0 | 339,157 | /s/ Srinivas Akkaraju | By Samsara BioCapital GP, LLC, its General Partner, By Srinivas Akkaraju, Managing Member | 0001699737 |
| Samsara BioCapital GP, LLC | 9.9% | 339,157 | 0 | 339,157 | /s/ Srinivas Akkaraju | By Srinivas Akkaraju, Managing Member | 0001888829 |
| Srinivas Akkaraju | 9.9% | 343,223 | 4,066 | 339,157 | /s/ Srinivas Akkaraju | Srinivas Akkaraju | 0001253170 |